Triple-Action Structure With Added Glucagon Retatrutide is a triple-action therapy that, like Lillys Mounjaro and Zepbound drugs, targets glucagon-like peptide-1, or GLP-1, and glucose-dependent insulinotropic polypeptide, or GIP, while also acting on the glucagon receptor
Understanding why it happens and what you can do about it is the first step toward regaining confidence and control
Liraglutide has been approved by the United States Food and Drug Administration (FDA) for long-term weight management (4)
Many people see little or no scale movement in weeks 12
Purchasing prescription medication without a prescription is illegal in the U.S
Still others say its about large companies keeping more profit- this makes little sense to me since only short-listed meds are permitted to be compounded- well, short-listed, like certain biologics